Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Unexpected results from a study of gene therapy for rheumatoid arthritis

April 21, 1998

COX-2 inhibitors claimed by AHP for arthritis, cancer and AD

April 20, 1998

Novel cell adhesion inhibitors discovered at Biogen

April 20, 1998

AnorMED seeks licensing partner for phase II rheumatoid arthritis drug

April 17, 1998

Pfizer presents new inhibitors of MMPs and/or TNF production

April 15, 1998

New COX-2-selective compounds in development at Merck Frosst

April 9, 1998

Aspartame has potent antiarthritic activity in preclinical models and arthritic subjects

April 8, 1998

Celtrix reports interim results of phase II clinical study of SomatoKine

April 8, 1998

HMR files for European, American approval of arthritis drug

April 7, 1998

Inhibitors of MMP enzymes synthesized at American Cyanamid

April 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...